Digital tools to reliably evaluate cognitive and neurological symptoms
This SIG targets digital tools that measures cognitive and motor symptoms in Alzheimer´s disease and Parkinson’s disease. We are specifically interested in their diagnostic and prognostic values, the ability to track disease progression and to detect effects of interventional studies as well as their implementation in clinical practice.
In alignment with MultiPark's strategic goals
- Understand the origins and progression of neurodegenerative disease
- Develop early and differential diagnostics and prognostics.
- Create new therapeutic approaches for prevention, disease modification and management of unmet medical needs
Overarching goals
To develop and evaluate digital tools for:
- Diagnosis and prognosis of Alzheimer’s and Parkinson’s disease
- Tracking progression of neurodegenerative diseases
Planned activities
- 1 seminar/semester
Convening person
Maria H. Nilsson
Associate professor